Asosiy kontentga oʻtish
Maqola

Natural killer cells in the human lung tumor microenvironment display immune inhibitory functions

Jules RussickSorbonne UniversitéPierre-Emmanuel JoubertCentre de Recherche des Cordeliers, Sorbonne Universite, Inserm, Universite de Paris, Team Inflammation, complement and cancer, F-75006, Paris, FranceMélanie Gillard-BocquetUniversité Paris CitéCarine TorsetSorbonne UniversitéMaxime MeylanSorbonne UniversitéFlorent PetitprezProgramme Cartes d'Identité des Tumeurs, Ligue Nationale Contre le Cancer, Paris, FranceMarie‐Agnès Dragon‐DureyCentre de Recherche des Cordeliers, Sorbonne Universite, Inserm, Universite de Paris, Team Inflammation, complement and cancer, F-75006, Paris, FranceSolenne MarmierUniversité Paris CitéAditi VarthamanUniversité Paris CitéNathalie JosseaumeUniversité Paris CitéClaire GermainUniversité Paris CitéJérémy GocCentre de Recherche des CordeliersMarie‐Caroline Dieu‐NosjeanSorbonne UniversitéPierre ValidireDepartment of Pathology, Institut Mutualiste Montsouris, Paris, FranceLudovic FournelDepartments of Pathology and Thoracic Surgery, Hospital Cochin Assistance Publique Hopitaux de Paris, F-75014, Paris, FranceLaurence ZitvogelUniversite Paris Saclay, Le Kremlin-Bicêtre, FranceGabriela BindeaUniversité Paris CitéAudrey Mansuet‐LupoCentre de Recherche des CordeliersDiane DamotteAssistance Publique – Hôpitaux de ParisMarco AlifanoCentre de Recherche des CordeliersIsabelle CremerCentre de Recherche des Cordeliers, Sorbonne Universite, Inserm, Universite de Paris, Team Inflammation, complement and cancer, F-75006, Paris, France
2020en
ABI

Annotatsiya

Background Natural killer (NK) cells play a crucial role in tumor immunosurveillance through their cytotoxic effector functions and their capacity to interact with other immune cells to build a coordinated antitumor immune response. Emerging data reveal NK cell dysfunction within the tumor microenvironment (TME) through checkpoint inhibitory molecules associated with a regulatory phenotype. Objective We aimed at analyzing the gene expression profile of intratumoral NK cells compared with non-tumorous NK cells, and to characterize their inhibitory function in the TME. Methods NK cells were sorted from human lung tumor tissue and compared with non- tumoral distant lungs. Results In the current study, we identify a unique gene signature of NK cell dysfunction in human non-small cell lung carcinoma (NSCLC). First, transcriptomic analysis reveals significant changes related to migratory pattern with a downregulation of sphingosine-1-phosphate receptor 1 (S1PR1) and CX3C chemokine receptor 1 (CX3CR1) and overexpression of C-X-C chemokine receptor type 5 (CXCR5) and C-X-C chemokine receptor type 6 (CXCR6). Second, cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and killer cell lectin like receptor (KLRC1) inhibitory molecules were increased in intratumoral NK cells, and CTLA-4 blockade could partially restore MHC class II level on dendritic cell (DC) that was impaired during the DCs/NK cell cross talk. Finally, NK cell density impacts the positive prognostic value of CD8 + T cells in NSCLC. Conclusions These findings demonstrate novel molecular cues associated with NK cell inhibitory functions in NSCLC.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar

2 ta iqtibos0 ta foydalanilgan manba